Ste20-like Proline/alanine-Rich Kinase (SPAK) Deficiency Exacerbates Experimental Colitis in Mouse (CAM1P.239)

Yutao Yan,Yu Hong,Yifei Cao,Xianrong Xu,Xiaohua Tan,Lei Yang
DOI: https://doi.org/10.4049/jimmunol.192.supp.47.15
2014-01-01
Abstract:Inflammatory bowel diseases (IBDs) are characterized by epithelial barrier disruption and alterations in immune regulation. Ste20-like proline/alanine-rich kinase (SPAK) plays a role in intestinal inflammation, but the underlying mechanisms need to be defined. Here, SPAK knockout (KO) C57BL/6 mice exhibited significant increase in translocation of intestinal bacteria into mucosa, accompanying with marked elevation in paracellular permeability to FITC-dextran and altered apical side tight junction sodium ion selectivity, compared to wild type (WT) mice. In murine models of colitis induced by dextran sulfate sodium (DSS) and trinitrobenzene sulfuric acid (TNBS), KO mice were more sensitive than WT mice, as demonstrated by colonoscopy features, histological characteristics and MPO activities. Consistent with these findings, KO mice showed decreased IL-10 levels and increased proinflammatory cytokine secretion. Co-immunoprecipitation and immunohistochemical assays demonstrated that SPAK is associated with PKCtheta and CD46, regulators of regulatory T cell differentiation and activation. Flow cytometry analysis found that KO mice had significant lower amount of T regulatory 1 (Tr1) cells in comparison with WT mice. In conclusions, SPAK deficiency compromises intestinal innate immune homeostasis, implying its important role as a potential intervention target against pathological responses in IBD.
What problem does this paper attempt to address?